Lexapro Lawsuit Lawyers

Lexapro lexapro bottleis a selective serotonin reuptake inhibitor (SSRI). An SSRI is an antidepressant that regulates serotonin, a chemical messenger. Lexapro (Escitalopram) is used for depression and general anxiety disorders. Common side effects include sleeplessness (insomnia), ejaculation disorder, nausea, sweating,  drowsiness, low sex drive, dry mouth, nausea.

Free Legal Consultation

If you or a loved one has been injured by Lexapro, contact an experienced Lexepro Lawyer at Matthews & Associates for a free legal consultation.

Black Box Warning

Like all antidepressants, Lexapro contains a black box warning of an increased risk of suicidal thoughts and behavior among children, adolescents, and young adults when starting treatment.

Lexapro side effects can zap a person’s vitality, according to anecdotal evidence. Many  prescribed Lexapro discover the drug’s effects to be more severe than their original condition. If this occurs, those injured by Lexapro may be entitled to compensation for medical expenses as well as other personal costs.

Lexapro was approved for treating major depressive disorder (MDD), and generalized anxiety disorder (GAD) in 2002. After receiving FDA approval, it was marketed as suitable for non-approved conditions. Lexapro lawsuits resulted from this illegal marketing

Lexapro Recall Information

Despite its mild to severe side effects, Lexapro has not been recalled. We will post such news immediately if it should occur.

Lexapro Lawsuit Information

If you or a loved one has experienced adverse side effects from the use of Lexapro, you may qualify for compensation to help with the cost of your medical expenses, as well as your pain and suffering.  To contact a Lexapro lawyer for a free consultation and Lexapro lawsuit information, call Matthews and Associates toll free at 1-888-520-5202.

FDA Warnings for Lexapro

Approved by the FDA in 2002, Lexapro is in a class of medicines called Selective Serotonin Reuptake Inhibitors, or SSRIs, and is used to treat depression and General Anxiety Disorder (GAD)

FDA announced in July 2006 that a case-controlled study showed infants born to mothers who took SSRIs after the 20th week of pregnancy were six times more likely to have persistent pulmonary hypertension (PPHN) compared with infants born to mothers who did not take SSRIs during pregnancy. The risk of a woman’s birthing an infant affected by PPHN is estimated at about 1-2 infants per 1000. Neonatal PPHN is associated with significant morbidity and mortality. FDA said this information reflects its current analysis of data available to FDA concerning SSRIs, such as Lexapro.

Since 2002, Lexapro has been used by millions of Americans for anxiety and depression. However, in July 2006, the FDA issued an alert announcing the results of a study looking at the use of antidepressant medicines during pregnancy by mothers of babies born with a serious condition called persistant pulmonary hypertension of the newborn (PPHN). The results showed that babies born to mothers who took Lexapro were more likely to develop PPHN.

Lexapro
◆  goes by the generic name escitalopram®.
◆ contains the active ingredient escitalopram
◆ was originally approved in 2002
◆  is manufactured by Forest Laboratories, Inc.
◆ is approved for
◆ in generic form was first approved Mar. 14, 2012

Off-label Uses of Lexapro

“Off label” means a use not approved by the FDA. These uses are not included in the approved language of a drug’s label and prescribing information. Off-label marketing is illegal, but it is legal for doctors to write prescriptions for off-label uses.

In 2010, Lexapro’s maker, Forest Pharmaceuticals, agreed to pay a $313 Million and plead guilty to obstruction of justice for illegal off-label promotion of Celexa, a predecessor of Lexepro. Forest Pharmaceuticals also pleaded guilty to submitting false claims to federal health care programs for Lexapro. Forest illegally marketed Lexapro for treatment of children prior to its approval for treatment of adolescents. Forest also engaged in a kickback scheme to coax doctors into prescribe Lexapro to children.

A Stanford School of Medicine study recommended that Lexapro and 13 other drugs be reviewed for their off-label use. Lexapro’s most common off-label use was for treatment of Bipolar Disorder. The study notes off-label use of medications is rampant. An author of the study noted, “When the volume of off-label use of any drug reaches the magnitude that we’re documenting, it suggests a role of the pharmaceutical industry in facilitating these types of uses.”

Lexapro Side Effects

While Lexapro may be effective for its indicated treatments of depression and general anxiety disorder, many side effects associated with the drug. Some can be severe. They include:

● rigid muscles, high fever, sweating, fast or uneven heartbeats, tremors, overactive reflexes;
● nausea, vomiting, diarrhea, loss of appetite, feeling unsteady, loss of coordination;
● headache, concentration or memory problems, weakness, confusion, hallucinations,             fainting, seizure, breathing problems.

Less serious side effects may include:

●  drowsiness, dizziness;
●  sleep problems (insomnia);
●  mild nausea, gas, heartburn, upset stomach, constipation;
weight changes;
●  decreased sex drive, impotence, or difficulty having an orgasm; or
●  dry mouth, yawning, ringing in your ears.

Lexapro FDA Alerts

In May 2011 the FDA released an alert regarding the potential link between Topamax and birth defects.
Topamax Resources

Lexapro Mediation Guide
Lexapro Drug Safety – FDA

Contact a Lexapro Lawyer Today

For a free, confidential case evaluation, contact an experienced Lexapro lawyer at Matthews and Associates by dialing toll-free at  1-888-520-5202 or fill out our contact form. We will answer any questions you may have regarding an Lexapro lawsuit.

Share